Skip to main content

Table 3 MAP and HR change

From: Effects of intravenous infusion of lidocaine and dexmedetomidine on inhibiting cough during the tracheal extubation period after thyroid surgery

Variables

LIDO group

DEX group

CON group

P value

(n = 60)

(n = 60)

(n = 60)

MAP (mmHg)

 Before induction

86.9 ± 12.6

83.6 ± 10.4

87.6 ± 13.4

0.167

 During tracheal extubation

84.8 ± 14.4

88.2 ± 14.5

101.4 ± 13.3*

0.000

 5 min after tracheal extubation

91.7 ± 16.5

90.8 ± 13.1

104.7 ± 15.7*

0.000

HR (beat/min)

 Before induction

79.8 ± 10.4

83.5 ± 13.4

83.6 ± 15.3

0.198

 During tracheal extubation

80.7 ± 12.4

79.4 ± 8.1

95.3 ± 13.6*

0.000

 5 min after tracheal extubation

86.6 ± 13.8

85.2 ± 11.6

101.1 ± 15.6*

0.000

  1. Categorical variables were presented as the mean ± standard deviation for all of the patients, with 60 cases in each group. LIDO group, iv. lidocaine; DEX group, iv. dexmedetomidine; CON group, iv. equal volume normal saline. MAP, mean arterial pressure; HR, heart rate. Compared with the LIDO group and the DEX group, both MAP and HR were significantly increased in the CON group during tracheal extubation and 5 min after tracheal extubation (*P = 0.000)